PharmaSGP Holding SE/€PSG
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About PharmaSGP Holding SE
PharmaSGP Holding SE is a European pharmaceutical company specializing in the development and sale of non-prescription consumer health products. The company's portfolio includes herbal medicines and health supplements designed for various therapeutic areas, including pain relief, sexual wellbeing, and skin health. Founded in 2008, PharmaSGP has focused on leveraging plant-based active ingredients to provide alternative treatment options. The company is headquartered in Gräfelfing, Germany, and operates primarily within the European market. PharmaSGP's strategic approach is underscored by its emphasis on innovation and its commitment to expanding an evidence-based product lineup.
Ticker
€PSG
Sector
Primary listing
XETRA
Employees
98
Headquarters
Website
PSG Metrics
BasicAdvanced
€371M
17.73
€1.63
-
€0.05
0.17%
Price and volume
Market cap
€371M
52-week high
€29.95
52-week low
€21.96
Average daily volume
3.9K
Dividend rate
€0.05
Financial strength
Current ratio
2.844
Quick ratio
2.167
Long term debt to equity
137.767
Total debt to equity
158.786
Dividend payout ratio (TTM)
86.19%
Interest coverage (TTM)
5.99%
Profitability
EBITDA (TTM)
36.026
Gross margin (TTM)
90.45%
Net profit margin (TTM)
14.96%
Operating margin (TTM)
21.52%
Effective tax rate (TTM)
24.84%
Revenue per employee (TTM)
€1,290,000
Management effectiveness
Return on assets (TTM)
13.64%
Return on equity (TTM)
52.68%
Valuation
Price to earnings (TTM)
17.729
Price to revenue (TTM)
2.653
Price to book
9.45
Price to tangible book (TTM)
-23.81
Price to free cash flow (TTM)
12.32
Free cash flow yield (TTM)
8.12%
Free cash flow per share (TTM)
2.346
Dividend yield (TTM)
0.17%
Forward dividend yield
0.17%
Growth
Revenue change (TTM)
15.20%
Earnings per share change (TTM)
7.40%
3-year revenue growth (CAGR)
16.05%
3-year earnings per share growth (CAGR)
20.52%
3-year dividend per share growth (CAGR)
4.26%
Bulls say / Bears say
PharmaSGP achieved organic revenue growth of 17.5% to €118.8 million in FY 2024, beating its own outlook and outpacing the OTC pharmacy market (PharmiWeb)
Adjusted EBITDA rose by 9.2% to €37.2 million in 2024, delivering a margin of 31.3% at the upper end of management's guidance (PharmiWeb)
International expansion resulted in a 68.9% jump in Italian revenue to €22.9 million in 2024, demonstrating successful diversification outside Germany (MarketScreener)
PharmaSGP’s adjusted EBITDA margin fell from 33.7% in 2023 to 31.3% in 2024, pointing to increasing cost pressure and margin challenges (PharmiWeb)
Revenue from "Other European countries" dropped by 11.0% to €3.3 million in 2024, showing weak performance in some non-core markets (MarketScreener)
Management's 2025 revenue outlook of €122.0–€128.0 million suggests growth of just 2.7%–7.7%, a sharp slowdown from the 17.5% growth seen in 2024 (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PharmaSGP Holding SE stock?
PharmaSGP Holding SE (PSG) has a market cap of €371M as of October 31, 2025.
What is the P/E ratio for PharmaSGP Holding SE stock?
The price to earnings (P/E) ratio for PharmaSGP Holding SE (PSG) stock is 17.73 as of October 31, 2025.
Does PharmaSGP Holding SE stock pay dividends?
Yes, the PharmaSGP Holding SE (PSG) stock pays dividends to shareholders. As of October 31, 2025, the dividend rate is €0.05 and the yield is 0.17%. PharmaSGP Holding SE has a payout ratio of 86.19% on a trailing twelve-month basis.
When is the next PharmaSGP Holding SE dividend payment date?
The next PharmaSGP Holding SE (PSG) dividend payment date is unconfirmed.
What is the beta indicator for PharmaSGP Holding SE?
PharmaSGP Holding SE (PSG) does not currently have a Beta indicator.